- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: durvalumab
Total 749 results
-
Gustave Roussy, Cancer Campus, Grand ParisWithdrawnMetastatic Colorectal Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Prostate Adenocarcinoma | Stomach Adenocarcinoma
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Targovax ASACompletedColorectal Cancer | Ovarian Cancer | Appendiceal CancerUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Asan Medical CenterActive, not recruitingMetastatic Colorectal CancerKorea, Republic of
-
AstraZenecaActive, not recruitingSmall-Cell Lung CancerPoland, Korea, Republic of, United States, Spain
-
AstraZenecaApproved for marketing
-
Mayo ClinicCompleted
-
Radboud University Medical CenterAstraZenecaCompletedNon-small Cell Lung CancerNetherlands
-
NSABP Foundation IncCompletedColorectal Cancer MetastaticUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLCCompletedMelanoma | Sarcoma | Breast Cancer | Solid Tumor | Prostate Cancer | Bladder Cancer | Head and Neck Squamous Cell Carcinoma | Cutaneous T-Cell Lymphoma | Renal Cancer | Merkel Cell Carcinoma | Testicular CancerUnited States
-
Centre hospitalier de l'Université de Montréal...AstraZenecaActive, not recruitingHead and Neck Squamous Cell Carcinoma | Metastatic Squamous Cell CarcinomaCanada
-
Yale UniversityCompletedBreast NeoplasmsUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Cure Brain Cancer Foundation...CompletedGlioblastomaUnited States, Australia
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research...TerminatedPhase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell TransplantMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLCCompletedRenal Cell Carcinoma | Cervical Cancer | Breast Cancer | Colorectal Cancer | Ovarian CancerUnited States
-
Ludwig Institute for Cancer ResearchXcovery Holding Company, LLC; Cancer Research Institute, New York City; MedImmune...CompletedCarcinoma | NSCLC | Non-small Cell Lung CancerUnited States
-
Ludwig Institute for Cancer ResearchCelgene; Cancer Research Institute, New York City; MedImmune LLCCompletedOvarian CancerUnited States, Switzerland
-
Ludwig Institute for Cancer ResearchBoehringer Ingelheim; MedImmune LLC; PharmaJet, Inc.; CureVac; Cancer Research Institute...CompletedNSCLC | Metastatic Non-small Cell Lung CancerUnited States
-
Baylor College of MedicineCompletedMesotheliomaUnited States
-
AIO-Studien-gGmbHAstraZenecaWithdrawn
-
Yale UniversityVA Connecticut Healthcare SystemCompleted
-
Dana-Farber Cancer InstituteAstraZenecaCompletedMuscle Invasive Bladder CancerUnited States
-
Duke UniversityAstraZenecaCompletedTriple Negative Breast CancerUnited States
-
Spanish Oncology Genito-Urinary GroupAstraZeneca; MFARActive, not recruiting
-
MedImmune LLCCompletedHead and Neck Cancer | Human Papilloma VirusUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); AstraZeneca; Juno Therapeutics, Inc.; MedImmune...TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedUnited States
-
ARCAGY/ GINECO GROUPActive, not recruitingEpithelial Ovarian Cancer | RelapseFrance
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Queen Mary University of LondonAstraZeneca; Vall d'Hebron Institute of OncologyActive, not recruitingRenal Clear Cell Carcinoma | Renal Papillary Cell CarcinomaUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterMedImmune LLCCompletedMetastatic Breast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZenecaWithdrawnOropharynx Cancer | HPV-Related Carcinoma | HPV Positive Oropharyngeal Squamous Cell CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBladder Cancer | Carcinoma in Situ of BladderUnited States
-
Massachusetts General HospitalNational Institute on Drug Abuse (NIDA)CompletedIntoxication Alcohol | Intoxication THC | Intoxication Combined Alcohol THCUnited States
-
ModernaTX, Inc.TerminatedOvarian Cancer | Relapsed/Refractory Solid Tumor Malignancies or LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCCompletedMetastatic Colorectal CancerUnited States
-
Canadian Cancer Trials GroupUniversity Health Network, Toronto; AstraZenecaActive, not recruitingBreast CancerCanada
-
Samsung Medical CenterActive, not recruitingGastric Adenocarcinoma | Malignant MelanomaKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedMetastatic Anaplastic Thyroid CancerUnited States
-
Fundación GECPCompletedSmall Cell Lung Cancer (SCLC)Spain
-
Yonsei UniversityActive, not recruitingSarcomaKorea, Republic of
-
Universitaire Ziekenhuizen KU LeuvenAstraZeneca; European Organisation for Research and Treatment of Cancer - EORTC and other collaboratorsActive, not recruitingOral Cavity Squamous Cell CarcinomaBelgium
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBreast Cancer | Hormone Receptor Positive TumorUnited States
-
European Organisation for Research and Treatment...CompletedColorectal Cancer | Liver MetastasesFrance, Netherlands, Switzerland, Germany, Austria, Sweden
-
Northwestern UniversityNational Cancer Institute (NCI); MedImmune LLC; Avon Breast Cancer FoundationCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu NegativeUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedHuman Papillomavirus Infection | Stage IVA Oral Cavity Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma | Stage IVB Oropharyngeal Squamous Cell Carcinoma | Stage IVC Oropharyngeal Squamous Cell Carcinoma | Stage I Oropharyngeal Squamous Cell Carcinoma | Stage II Oropharyngeal... and other conditionsUnited States
-
NSABP Foundation IncCompletedRectal CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); AstraZeneca; MedImmune LLCCompletedMalignant Glioma | Recurrent GlioblastomaUnited States
-
MedImmune LLCAstraZenecaCompletedCarcinoma, Non-Small-Cell LungUnited States, Korea, Republic of, Japan
-
Seoul National University HospitalChungnam National University Hospital; Korean Cancer Study GroupCompletedHead and Neck Neoplasms | HNSCCKorea, Republic of